Atosiban

For research use only. Not for therapeutic Use.

  • CAT Number: I005420
  • CAS Number: 90779-69-4
  • Molecular Formula: C43H67N11O12S2
  • Molecular Weight: 994.2
  • Purity: ≥95%
Inquiry Now

Atosiban (Cat.No:I005420) is a synthetic peptide used as a tocolytic agent to delay or inhibit premature labor. It acts as an antagonist of the hormone oxytocin, which stimulates uterine contractions. Atosiban competitively binds to the oxytocin receptor, inhibiting the oxytocin-induced contractions. It is commonly administered by injection and has a relatively short half-life.


Catalog Number I005420
CAS Number 90779-69-4
Synonyms

RW22164; Tractocile

Molecular Formula C43H67N11O12S2
Purity ≥95%
Target Vasopressin Receptor
Solubility DMSO: < 10.3 mg/mL
Storage Store at -20°C
IUPAC Name (2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
InChI InChI=1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63)/t23-,24+,27-,28+,29-,30-,31-,35-,36-/m0/s1
InChIKey VWXRQYYUEIYXCZ-OBIMUBPZSA-N
SMILES CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O InChIKey: VWXRQYYUEIYXCZ-OBIMUBPZSA-N
Reference

<p>
[1]. Sanu O, et al. Critical appraisal and clinical utility of atosiban in the management of preterm labor. Ther Clin Risk Manag. 2010 Apr 26;6:191-9.&nbsp;
</p>
<p>
[2]. Akerlund M, et al. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin. Acta Obstet Gynecol Scand. 1985;64(6):499-504.
</p>

Request a Quote